Hot Alert: Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), Diversified Restaurant Holdings, Inc. (NASDAQ:BAGR), Hilton Worldwide Holdings Inc. (NYSE:HLT), IDEXX Laboratories (NASDAQ:IDXX), Abbott Laboratories (NYSE:ABT)

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), announced that new Locilex® microbiology data will be presented at the American Society for Microbiology’s Interscience Conference of Antimicrobial Agents and Chemotherapy and International Society of Chemotherapy’s International Congress of Chemotherapy and Infection (ICAAC/ICC 2015) scientific meeting in San Diego, California, September 17-21, 2015. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) belongs to Healthcare sector. Its weekly performance is -7.78%. On last trading day company shares ended up $15.40. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) distance from 50-day simple moving average (SMA50) is 5.44%.

Diversified Restaurant Holdings Inc. (NASDAQ:BAGR) on Thursday reported a loss of $3.3 million in its second quarter. On a per-share basis, the Southfield, Michigan-based company said it had a loss of 13 cents. Losses, adjusted for one-time gains and costs, came to 2 cents per share.
The operator of Bagger Dave’s Burger Tavern and franchised Buffalo Wild Wings restaurants posted revenue of $36.9 million in the period. Diversified Restaurant Holdings, Inc. (NASDAQ:BAGR) shares moved down -18.26% in last trading session and ended the day at $3.00. BAGR Gross Margin is 71.00% and its return on assets is -1.30%. Diversified Restaurant Holdings, Inc. (NASDAQ:BAGR) quarterly performance is -25.93%.

Hilton Worldwide Holdings Inc. (NYSE:HLT) initiated a regular quarterly cash dividend with the announcement on July 29, 2015 of a dividend of $0.07 per share on shares of its common stock to be paid on or before September 25, 2015 to stockholders of record of its common stock as of the close of business on August 14, 2015. On 07 August, Hilton Worldwide Holdings Inc. (NYSE:HLT) shares increased 0.86% and was closed at $25.91. Hilton Worldwide Holdings Inc. (NYSE:HLT) year to date (YTD) performance is -0.69%.

On 30 July, IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported revenues for the second quarter of 2015 of $413 million, an increase of 6% compared to the prior year period. Impacts from the strengthening of the US dollar reduced reported revenue growth by 7%. IDEXX Laboratories, Inc. (NASDAQ:IDXX) ended the last trading day at $76.55. Company weekly volatility is calculated as 2.66% and price to cash ratio as 20.47. IDEXX Laboratories, Inc. (NASDAQ:IDXX) showed a weekly performance of 5.25%.

On 30 July, Abbott Laboratories (NYSE:ABT) announced that it has entered into an agreement to purchase Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies. Under the terms of the agreement, Abbott will acquire the equity of Tendyne that it does not already own for $225 million upfront, resulting in a total transaction value of $250 million, plus potential future payments tied to regulatory milestones. Abbott Laboratories (NYSE:ABT) shares moved down -0.42% in last trading session and ended the day at $50.11. ABT Gross Margin is 56.40% and its return on assets is 10.70%. Abbott Laboratories (NYSE:ABT) quarterly performance is 5.85%.

Leave a Reply

Your email address will not be published. Required fields are marked *